Results 301 to 310 of about 68,882 (316)

Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO‐incompatible kidney transplantation and the associated risk factors

International journal of urology, 2019
To analyze the prevalence of systemic de novo thrombotic microangiopathy in ABO‐incompatible kidney transplantation and risk factors associated with this condition.
M. Tasaki, K. Saito, Y. Nakagawa, N. Imai, Yumi Ito, Y. Yoshida, M. Ikeda, S. Ishikawa, I. Narita, Kota Takahashi, Y. Tomita   +10 more
semanticscholar   +1 more source

Microangiopathy of the brain and retina

Neurology, 1979
Two women (26 and 40 years old) developed an unusual microangiopathy that affected the brain and retina. Psychiatric symptoms initially overshadowed the subacute features of the progressive neurologic disorder. Ophthalmoscopic findings of multifocal branch retinal artery occlusions provided clinical evidence of vasculopathy.
John B. Selhorst, John M. Hardman, John O. Susac   +2 more
openaire   +2 more sources

Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics

Nature Reviews Nephrology, 2021
F. Fakhouri, V. Frémeaux-Bacchi
semanticscholar   +1 more source

Eculizumab for transplant‐associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients

European Journal of Haematology, 2018
To evaluate response rates and survival in adults with transplant‐associated thrombotic microangiopathy (TA‐TMA) after allogeneic hematopoietic stem cell transplantation (HSCT) who were treated with eculizumab (ECU).
Joslyn Rudoni, A. Jan, C. Hosing, F. Aung, Jason C Yeh   +4 more
semanticscholar   +1 more source

Hyperinsulinism and Cerebral Microangiopathy

Stroke, 1996
Background and Purpose High insulin levels are a recognized risk factor for atherosclerosis. Microvascular endothelium is more susceptible to metabolic and mitogenic effects of insulin than large-vessel endothelium. Besides their atherogenic effect, high insulin levels impair fibrinolysis by enhancing plasminogen activator ...
Darius G. Nabavi, Michael Edelmann, Hans-Christian Buschmann, D. Georgiadis, Achim Schick, P. Zunker, E. Bernd Ringelstein   +6 more
openaire   +3 more sources

Syndromes of Thrombotic Microangiopathy.

The Medical clinics of North America, 2017
J. Shatzel, Jason A Taylor
semanticscholar   +1 more source

Thrombotic microangiopathies

Critical Reviews in Oncology/Hematology, 1991
P, Ruggenenti, G, Remuzzi
openaire   +2 more sources

Microangiopathies

Medicine, 2003
openaire   +1 more source

Bilirubin and Microangiopathy

Ophthalmology, 2012
openaire   +3 more sources

Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis

Clinical Rheumatology, 2020
J. Mejía-Vilet, I. Gómez-Ruiz, C. Cruz, R. A. Méndez-Pérez, Roque A. Comunidad-Bonilla, N. Uribe-Uribe, C. Núñez-Álvarez, L. Morales-Buenrostro   +7 more
semanticscholar   +1 more source